Vimarsana
Biggest News Aggregation in the World

Page 45 - Contract Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contract Development Today - Breaking & Trending Today

Syngene International to invest $100mn annually in research and biologics - Vimarsana News

Syngene International to invest $100mn annually in research and biologics

The company has made a cumulative investment of approximately Rs 4,500 crores.

Fidelity Asian Values Plc - Annual Financial Report - Vimarsana News

Fidelity Asian Values Plc - Annual Financial Report

FIDELITY ASIAN VALUES PLCFinal Results for the year ended 31 July 2023 ...

Health Canada Approves Eurofins CDMO Alphora Inc.'s Cannabis Drug License for Synthetic Phytocannabinoids - Vimarsana News

Health Canada Approves Eurofins CDMO Alphora Inc.'s Cannabis Drug License for Synthetic Phytocannabinoids

LUXEMBOURG, October 11, 2023--Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023. This compliments the Institutional Research License obtained through Health Canada in June 2021 for its Mississauga development site and a Standard Processing License obtained for the Oakville, Ontario manufacturing operation in May 2022.

Source: yahoo.com
Health Canada Approves Eurofins CDMO Alphora Inc.'s Cannabis Drug License for Synthetic Phytocannabinoids | Region - Vimarsana News

Health Canada Approves Eurofins CDMO Alphora Inc.'s Cannabis Drug License for Synthetic Phytocannabinoids | Region

LUXEMBOURG--(BUSINESS WIRE)--Oct 11, 2023--

India: The quality pharmacy of the world - Vimarsana News

India: The quality pharmacy of the world

Indian pharmaceutical companies have immense potential to increase their share in the $1.4 trillion global pharma industry The global pharmaceutical space has witnessed massive evolution in the last three years, following the pressure mounted by the COVID-19 pandemic. Within a short period, India